Company: INVUP
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001493152-25-011912
Chunk: 98

Company: Investview, Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 8
Chunk 98
---
 of which was repaid during the period.

[3]On
                                            November 9, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled
                                            by a member of our Board of Directors and entered into a convertible promissory note. The
                                            note is secured by collateral of the Company and its subsidiaries. The note bears interest
                                            at 38.5% per annum, made up of a 25% interest rate per annum and a facility fee of 13.5%
                                            per annum, payable monthly beginning February 1, 2021, and the principal is due and payable
                                            on April 27, 2030. Per the terms of the agreement, the note is convertible into common stock
                                            at a conversion price of $0.007 per share. At inception we recorded a beneficial conversion
                                            feature and debt discount of $1,300,000. During the six months ended June 30, 2025, we recognized
                                            $68,091 of the debt discount into interest expense and expensed an additional $250,248
                                            of interest expense on the note, all of which was repaid during the period.

  [4]
  On March 22, 2021, we entered into Securities Purchase Agreements
to purchase 100% of the operating assets of SSA Technologies LLC (“SSA”), an entity that owns and operates a FINRA-registered
broker-dealer. SSA is controlled and partially owned by Joseph Cammarata, our former Chief Executive Officer. (See NOTE 11). Commencing
upon execution of the agreements and through the closing of the transactions, we agreed to provide certain transition service arrangements
to SSA. In connection with the transactions, we entered into a Working Capital Promissory Note with SSA under which SSA was to have advanced
to us up to $1,500,000 before the end of 2021; however, SSA only provided advances of $1,200,000, to date. The note bears interest at
the rate of 0.11% per annum. The note was due and payable by January 31, 2022; however, has not yet been repaid as we consider our legal
options in light of SSA’s failure to complete its funding obligations, and the other damages we sustained as a result of the actions
of Mr. Cammarata. During the six months ended June 30, 2025,